233275-76-8
中文名稱
MK 0343
英文名稱
MK 0343
CAS
233275-76-8
分子式
C19H17F2N7O
分子量
397.38
MOL 文件
233275-76-8.mol
更新日期
2023/03/20 15:41:21
233275-76-8 結(jié)構(gòu)式
基本信息
中文別名
7-環(huán)丁基-3-(2,6-二氟苯基)-6-((1-甲基-1H-1,2,4-三氮唑-5-乙基)甲氧基)-[1,2,4]三氮唑[4,3-B]噠嗪 英文別名
MK 0343MRK-409
MK-0343 >=98% (HPLC)
7-Cyclobutyl-3-(2,6-difluorophenyl)-6-[(1-methyl-1H-1,2,4-triazol-5-yl)methoxy]-1,2,4-triazo[4,3-b]pyridazine
7-Cyclobutyl-3-(2,6-difluorophenyl)-6-[(1-methyl-1H-1,2,4-triazol-5-yl)methoxy]-1,2,4-triazolo[4,3-b]pyridazine
1,2,4-Triazolo[4,3-b]pyridazine, 7-cyclobutyl-3-(2,6-difluorophenyl)-6-[(1-Methyl-1H-1,2,4-triazol-5-yl)Methoxy]-
物理化學(xué)性質(zhì)
密度1.57±0.1 g/cm3(Predicted)
儲存條件Inert atmosphere,2-8°C
溶解度DMSO：可溶10mg/mL，澄清
酸度系數(shù)(pKa)2.11±0.10(Predicted)
形態(tài)粉末
顏色白色至米色
InChI1S/C19H17F2N7O/c1-27-16(22-10-23-27)9-29-19-12(11-4-2-5-11)8-15-24-25-18(28(15)26-19)17-13(20)6-3-7-14(17)21/h3,6-8,10-11H,2,4-5,9H2,1H3
InChIKeyGOIFCXRIFSYPFG-UHFFFAOYSA-N
SMILESCn1ncnc1COc2nn3c(nnc3cc2C4CCC4)-c5c(F)cccc5F
MK 0343價格(試劑級)
| 報價日期 | 產(chǎn)品編號 | 產(chǎn)品名稱 | CAS號 | 包裝 | 價格 |
| 2026/06/05 | HY-101869 | MK 0343 MK-0343 | 233275-76-8 | 5mg | 1500元 |
| 2026/06/05 | HY-101869 | MK-0343 | 233275-76-8 | 10 mM * 1 mLin DMSO | 1650元 |
| 2026/06/05 | HY-101869 | MK 0343 MK-0343 | 233275-76-8 | 10 mg | 2500元 |
常見問題列表
生物活性
MK0343 (MRK-409) 是一種口服生物可利用的 GABAA 受體亞型選擇性部分激動劑。MK0343 是一種非鎮(zhèn)靜的抗焦慮藥物。靶點
Ki: 0.22 nM (rGABA A α1), 0.4 nM (rGABA A α2) , 0.21 nM (rGABA A α3), 78 nM (rGABA A α4), 0.23 nM (rGABA A α5), 980 nM (rGABA A α6)
體內(nèi)研究
MK0343 readily penetrates the brain in rats and occupies the benzodiazepine site of GABAA receptors, measured using an in vivo [
3
H]flumazenil binding assay, with an Occ
50
of 2.2?mg/kg p.o. and a corresponding plasma EC
50
of 115?ng/mL.
| Animal Model: | Male Sprague-Dawley rats (approximately 250–300g) (pharmacokinetics) |
| Dosage: | 1, 2 or 3?mg/kg |
| Administration: | Oral administration |
| Result: | Readily penetrated the brain in rats and occupies the benzodiazepine site of GABAA receptors, with an Occ 50 of 2.2?mg/kg p.o. and a corresponding plasma EC 50 of 115?ng/mL. |